Td Asset Management Inc Y M Abs Therapeutics, Inc. Transaction History

Td Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$23.81 - $33.78 $636,988 - $903,716	-26,753 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$21.57 - $31.37 $28,041 - $40,781	1,300 Added 5.11%	26,753 $697,000
Q2 2019 Aug 01, 2019	BUY	$19.51 - $28.31 $51,194 - $74,285	2,624 Added 11.49%	25,453 $582,000
Q1 2019 May 08, 2019	BUY	$18.21 - $26.21 $80,706 - $116,162	4,432 Added 24.09%	22,829 $598,000
Q4 2018 Feb 01, 2019	BUY	$15.41 - $28.92 $1,541 - $2,892	100 Added 0.55%	18,397 $374,000
Q3 2018 Nov 01, 2018	BUY	$24.0 - $26.97 $439,128 - $493,470	18,297 New	18,297 $486,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.